Literature DB >> 9525614

Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface.

S L Thomas1, M Oft, H Jaksche, G Casari, P Heger, M Dobrovnik, D Bevec, J Hauber.   

Abstract

The expression of human immunodeficiency virus type 1 (HIV-1) structural proteins requires the action of the viral trans-regulatory protein Rev. Rev is a nuclear shuttle protein that directly binds to its cis-acting Rev response element (RRE) RNA target sequence. Subsequent oligomerization of Rev monomers on the RRE and interaction of Rev with a cellular cofactor(s) result in the cytoplasmic accumulation of RRE-containing viral mRNAs. Moreover, Rev by itself is exported from the nucleus to the cytoplasm. Although it has been demonstrated that Rev multimerization is critically required for Rev activity and hence for HIV-1 replication, the number of Rev monomers required to form a trans-activation-competent complex on the RRE is unknown. Here we report a systematic analysis of the putative multimerization domains within the Rev trans-activator protein. We identify the amino acid residues which are part of the proposed single hydrophobic surface patch in the Rev amino terminus that mediates intermolecular interactions. Furthermore, we show that the expression of a multimerization-deficient Rev mutant blocks HIV-1 replication in a trans-dominant (dominant-negative) fashion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525614      PMCID: PMC109739     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  111 in total

1.  Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator.

Authors:  M Hammerschmid; D Palmeri; M Ruhl; H Jaksche; I Weichselbraun; E Böhnlein; M H Malim; J Hauber
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

2.  Sequence requirements for Rev multimerization in vivo.

Authors:  S J Madore; L S Tiley; M H Malim; B R Cullen
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

5.  A second post-transcriptional trans-activator gene required for HTLV-III replication.

Authors:  J Sodroski; W C Goh; C Rosen; A Dayton; E Terwilliger; W Haseltine
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

6.  Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.

Authors:  D Bevec; B Volc-Platzer; K Zimmermann; M Dobrovnik; J Hauber; G Veres; E Böhnlein
Journal:  Hum Gene Ther       Date:  1994-02       Impact factor: 5.695

7.  HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm.

Authors:  N Richard; S Iacampo; A Cochrane
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

8.  A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression.

Authors:  D A Mann; I Mikaélian; R W Zemmel; S M Green; A D Lowe; T Kimura; M Singh; P J Butler; M J Gait; J Karn
Journal:  J Mol Biol       Date:  1994-08-12       Impact factor: 5.469

9.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

10.  Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.

Authors:  U Fischer; S Meyer; M Teufel; C Heckel; R Lührmann; G Rautmann
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more
  28 in total

1.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element.

Authors:  Michael A DiMattia; Norman R Watts; Stephen J Stahl; Christoph Rader; Paul T Wingfield; David I Stuart; Alasdair C Steven; Jonathan M Grimes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

3.  The UL69 transactivator protein of human cytomegalovirus interacts with DEXD/H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of unspliced RNA.

Authors:  Peter Lischka; Zsolt Toth; Marco Thomas; Regina Mueller; Thomas Stamminger
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

4.  A DEAD-Box Helicase Mediates an RNA Structural Transition in the HIV-1 Rev Response Element.

Authors:  John A Hammond; Rajan Lamichhane; David P Millar; James R Williamson
Journal:  J Mol Biol       Date:  2017-01-31       Impact factor: 5.469

5.  Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer.

Authors:  Thomas Vercruysse; Sonalika Pawar; Wim De Borggraeve; Els Pardon; George N Pavlakis; Christophe Pannecouque; Jan Steyaert; Jan Balzarini; Dirk Daelemans
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

6.  Nuclear Export Signal Masking Regulates HIV-1 Rev Trafficking and Viral RNA Nuclear Export.

Authors:  Ryan T Behrens; Mounavya Aligeti; Ginger M Pocock; Christina A Higgins; Nathan M Sherer
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

7.  Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2).

Authors:  Hatice Akarsu; Wilhelm P Burmeister; Carlo Petosa; Isabelle Petit; Christoph W Müller; Rob W H Ruigrok; Florence Baudin
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

8.  A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells.

Authors:  Carina Banning; Jörg Votteler; Dirk Hoffmann; Herwig Koppensteiner; Martin Warmer; Rudolph Reimer; Frank Kirchhoff; Ulrich Schubert; Joachim Hauber; Michael Schindler
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

9.  The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions.

Authors:  Yoshiyuki Hakata; Masami Yamada; Naoto Mabuchi; Hisatoshi Shida
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Structural model of the Rev regulatory protein from equine infectious anemia virus.

Authors:  Yungok Ihm; Wendy O Sparks; Jae-Hyung Lee; Haibo Cao; Susan Carpenter; Cai-Zhuang Wang; Kai-Ming Ho; Drena Dobbs
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.